Media Centre
Latest press releases
-
Truqap plus Faslodex approved in Japan for patients with advanced HR-positive breast cancer
-
Beyfortus approved in Japan for the prevention of RSV disease in infants
-
Ultomiris approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
-
Tagrisso with the addition of chemotherapy showed favourable trend in overall survival in EGFR-mutated advanced lung cancer with further follow up in FLAURA2 Phase III trial
-
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.